Sofiva Genomics Co.,Ltd. (TPEX:6615)
33.10
+0.30 (0.91%)
Apr 29, 2026, 1:17 PM CST
Sofiva Genomics Revenue
In the year 2025, Sofiva Genomics had annual revenue of 385.71M TWD, down -14.91%. Sofiva Genomics had revenue of 95.69M in the quarter ending December 31, 2025, a decrease of -7.52%.
Revenue
385.71M
Revenue Growth
-14.91%
P/S Ratio
1.84
Revenue / Employee
n/a
Employees
104
Market Cap
708.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 385.71M | -67.61M | -14.91% |
| Dec 31, 2024 | 453.31M | -13.49M | -2.89% |
| Dec 31, 2023 | 466.80M | -28.98M | -5.84% |
| Dec 31, 2022 | 495.78M | -12.64M | -2.49% |
| Dec 31, 2021 | 508.42M | 19.55M | 4.00% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puriblood Medical | 117.35M |
| Kim Forest Enterprise | 549.14M |
| Pharmigene | 149.25M |
| Genetics Generation Advancement | 603.11M |
| Welgene Biotech | 375.94M |
| DIVA Laboratories | 868.84M |
| BIONET | 1.24B |